Table 4

The OR between fasting insulin and the occurrence of high-risk hs-CRP (>2 mg/L)

OR(95% CI) between fasting insulin (µIU/mL) and high-risk hs-CRP
Outcomes<55–1010–15>15p Value
Unadjusted1(ref)1.26 (0.89–1.79)2.78 (1.79–4.33)4.59 (2.77–7.58)<0.001
Model I1(ref)1.30 (0.92–1.84)2.91 (1.87–4.53)4.78 (2.87–7.94)<0.001
Model II1(ref)1.27 (0.89–1.81)3.02 (1.90–4.80)4.78 (2.76–8.27)<0.001
  • Participants with fasting insulin <5 µIU/mL were reference group. ORs are given with 95% CI in parentheses.

  • Model I: adjusted for sex, age.

  • Model II: adjusted for model I + alcohol, smoking, exercise, total energy intake.

  • hs-CRP, high-sensitivity C reactive protein.